Palliative Patients Clinical Trial
— MAPSOfficial title:
Multiprofessional Advance Care Planning and Shared Decision-making for End of Life Care MAPS Trial
Verified date | June 2016 |
Source | University of Zurich |
Contact | n/a |
Is FDA regulated | No |
Health authority | Switzerland: Ethikkommission |
Study type | Interventional |
Multiprofessional Advance Care Planning and shared decision making for end of live care for
terminal patients and their relatives.
The aim of this study is to develop, implement and test a complex intervention for improving
patients' preparation for and participation in end of life decisions. In cooperation with
local, national and international partners, the investigators will focus on strategies to
enhance advance care planning and shared decision making on end of life issues, and
documentation and transferability of end of life decisions across health care settings in
coordinated approach involving patients, their families and care givers (in and out of
hospital).
Status | Completed |
Enrollment | 115 |
Est. completion date | August 2015 |
Est. primary completion date | April 2015 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion criteria: -patients in which the treating physician on the ward would not be
surprised if the patient died during the next year (surprise question of Weissman et al
2011) - male and female patients above 18 years of age - signed informed consent after being informed - patients able to appoint a surrogate decision maker (SM) and/or responsible physician to be contacted after discharge Exclusion criteria: -patients not capable of speaking german - patients having no responsible physician to be contacted after discharge and no relative/future surrogate decision maker (SM) - inhouse patients being discharged within the next 2 days or ambulatory patients not regularly coming to the wards (at least every two month) - patients assessed by their physician to be in obvious denial of their situation (illness/prognosis) |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Supportive Care
Country | Name | City | State |
---|---|---|---|
Switzerland | University Hospital Zurich, Clinical Ethics | Zurich | ZH |
Lead Sponsor | Collaborator |
---|---|
University of Zurich |
Switzerland,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | end of life wish on resuscitation known (if alive) or fulfilled(if dead) after 6 month by responsible physician and/or surrogate decision maker (SM) | during 2 weeks six months after discharge | No | |
Secondary | end of live decisions on last place of care, antibiotics for pneumonia, feeding tube, intravenous fluids, dialysis, intubation and sedation, | during 2 weeks six months after discharge | No | |
Secondary | decisional conflict scale ("DCS"), O Connor et al 1995 | at discharge and during 2 Weeks six months after discharge | No | |
Secondary | Satisfaction with information and care, (see Detering et al 2010) | at discharge | No | |
Secondary | Hospital Anxiety and Depression scale ("HADS") | discharge and during 2 weeks six months after discharge | No | |
Secondary | Having an Advance directive | at discharge, during 2 weeks three months after discharge and during 2 weeks six months after discharge | No | |
Secondary | Having an appointed surrogate decision maker | at discharge, during 2 weeks three month after discharge and during 2 weeks six month after discharge | No | |
Secondary | Any hospital stay | during 2 weeks three months after discharge and during 2 weeks six months after discharge | No | |
Secondary | Decisions regarding end of life issues already having been made/taken place | during 2 weeks six months after discharge | No | |
Secondary | open question on important medical decisions being made | during 2 weeks three months after discharge | No | |
Secondary | Treatment against patients wishes | during 2 weeks three months after discharge and during 2 weeks six months after discharge, or 3 month after death | Yes | |
Secondary | Distress of Patients or relatives because of content of the consultation | at discharge, during 2 weeks three months after discharge and during 2 weeks six months after discharge | Yes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05054647 -
Mental Stress Symptoms in Family Caregivers of Palliative Patients
|